Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQU3H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $195,186
Award facts
- Contract value 100% obligated
- $195,185.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $195K to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL pens on January 12, 2026, with completion expected by January 13, 2026. This competitive award, issued without set-aside designation, represents a firm fixed-price transaction for pharmaceutical delivery to support federal medical supply needs. The award was executed under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $1 billion through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related healthcare supplies to federal government agencies. The company's performance location is located at its corporate office in Conshohocken, Pennsylvania. Dupixent is a biologic medication used for treating conditions such as atopic dermatitis, eczema, and asthma, supporting the Defense Health Agency and broader military healthcare system requirements for specialized pharmaceutical treatments.
Quick answers
Who was awarded contract SPE2DR26FQU3H?
SPE2DR26FQU3H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FQU3H worth?
The government has obligated $195,186 on SPE2DR26FQU3H.
Is contract SPE2DR26FQU3H an order under another contract?
Yes. SPE2DR26FQU3H is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU3H competed?
The extent of competition for SPE2DR26FQU3H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award